Skip to main content

Borregaard ASA: Operational issues and lower biovanillin demand in the 4th quarter

Written by Customer Service on . Posted in Public Companies.

During the 4th quarter of 2023, operational issues have affected production at the Sarpsborg site, reducing the result mainly in BioMaterials. Following the annual maintenance stop in October, the production volumes, quality, and ability to utilise internal bioenergy have been temporarily reduced. This is due to various failures in production equipment after maintenance, as well as prolonged commissioning of new equipment. The operational issues have now been addressed, and no carry-over effects are expected into the 1st quarter of 2024.

The result in BioSolutions will be negatively impacted by lower sales volume of biovanillin in the 4th quarter. This is mainly due to lower demand for biovanillin, which is increasingly affected by a significant expansion in the global supply of synthetic vanillin and ethyl vanillin.

In total, the negative EBITDA effect is estimated to be in the range of NOK 80-100 million for the Group in the 4th quarter. The temporary operational issues at the Sarpsborg site represent more than half of this effect.    

Sarpsborg, 9 December 2023

Contact:
Director Investor Relations, Knut-Harald Bakke, +47 905 79 164
Director Communications, Tone Horvei Bredal, +47 924 67 711

This information is considered to be inside information pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to Section 5 – 12 of the Norwegian Securities Trading Act.

This stock exchange announcement was published by Knut-Harald Bakke, Director Investor Relations at Borregaard ASA, on 9 December 2023 at 12:10 CET.

 

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.